Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 04-2021 | 01-2021 | 10-2020 | 07-2020 | 04-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,894 | 3,002 | 3,541 | 3,914 | 2,097 |
| Receivables | 221 | 466 | 560 | 1,089 | 1,607 |
| Inventories | 568 | 618 | 733 | 547 | 282 |
| TOTAL | $3,718 | $4,115 | $4,880 | $5,566 | $3,996 |
| Non-Current Assets | |||||
| PPE Net | 747 | 771 | 465 | 316 | 328 |
| Intangibles | 381 | 400 | 421 | 441 | 462 |
| TOTAL | $1,128 | $1,171 | $886 | $757 | $790 |
| Total Assets | $4,846 | $5,286 | $5,766 | $6,323 | $4,786 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 239 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 557 | 617 | 773 | 1,344 | 1,286 |
| Accrued Expenses | 142 | 163 | 133 | 168 | 205 |
| TOTAL | $938 | $780 | $906 | $1,512 | $1,491 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $938 | $780 | $906 | $1,512 | $1,491 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,223 | 87,223 | 87,073 | 87,073 | 86,891 |
| Common Shares | 873 | 873 | 871 | 871 | 869 |
| Retained earnings | -125,060 | -124,249 | -123,654 | -123,474 | -124,796 |
| TOTAL | $3,908 | $4,506 | $4,860 | $4,811 | $3,295 |
| Total Liabilities And Equity | $4,846 | $5,286 | $5,766 | $6,323 | $4,786 |